| 8721/16820 | US=1-A / Farmacologia Skidgel RA, Erdos EG. Histamina, bradicinina e seus antagonistas. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 563-84. ISBN 85-6330801-6. HISTAMINA. HISTORICO; HISTAMINA. FUNCOES; HISTAMINA. EFEITOS FARMACOLOGICOS; HISTAMINA. APLICACOES CLINICAS; ANTAGONISTAS DO RECEPTOR H1; ANTAGONISTAS DO RECEPTOR H1. PROPRIEDADES FARMACOLOGICAS; ANTAGONISTAS DO RECEPTOR H1. USOS TERAPEUTICOS; ANTI-HISTAMINICOS; BRADICININA; CALIDINA |
| 8722/16820 | US=1-A / Farmacologia Smyth EM, Burke A, FitzGerald GA. Autacóides derivados de lipídios: eicosanóides e fator de ativação das plaquetas. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 585-600. ISBN 85-6330801-6. FATOR DE ATIVACAO DAS PLAQUETAS; EICOSANOIDES. PROPRIEDADES FARMACOLOGICAS; EICOSANOIDES. USOS TERAPEUTICOS |
| 8723/16820 | US=1-A / Farmacologia Burke A, Smyth E, FitzGerald GA. Analgésicos-antipiréticos; farmacoterapia da gota. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 601-38. ISBN 85-6330801-6. ANTIINFLAMATORIOS NAO-ESTEROIDES; ANTIINFLAMATORIOS NAO-ESTEROIDES. EFEITOS TERAPEUTICOS; ANTIINFLAMATORIOS NAO-ESTEROIDES. EFEITOS ADVERSOS; INTERACOES MEDICAMENTOSAS; ACIDO ACETILSALICILICO; DIFLUNISAL; PARACETAMOL; INDOMETACINA; SULINDACO; ETODOLACO; FENAMATO; TOLMETINA; CETOROLACO; DICLOFENACO; ACIDO PROPIONICO; IBUPROFENO; NAPROXENO; FENOPROFENO; CETOPROFENO; FLURBIPROFENO; OXAPROZINA; ACIDOS ENOLICOS; PIROXICAM; MELOXICAM; NABUMETONA; DERIVADOS DE PIRAZOLONA; CICLOOXIGENASE 2; CELECOXIBE; VALDECOXIBE; ROFECOXIBE; APAZONA; NIMESSULIDA; ARTRITE REUMATOIDE; FARMACOTERAPIA DA GOTA; COLCHICINA; ALOPURINOL; RASBURICASE; AGENTES URICOSURICOS; PROBENECIDA; SULFIMPIRAZONA; BENZOBROMARONA |
| 8724/16820 | US=1-A / Farmacologia Jackson EK. Vasopressina e outros agentes que afetam a conservação renal de água. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 687-703. ISBN 85-6330801-6. VASOPRESSINA; FISIOLOGIA DA VASOPRESSINA; FARMACOLOGIA DA VASOPRESSINA; AGONISTAS DOS RECEPTORES DE VASOPRESSINA; ANTAGONISTAS DOS RECEPTORES DE VASOPRESSINA; DIABETES INSIPIDO; SINDROME DE SECRECAO INAPROPRIADA DE HORMONIO ANTIDIURETICO; PEPTIDIOS DE VASOPRESSINA |
| 8725/16820 | US=1-A / Farmacologia Jackson EK. Renina e angiotensina. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 705-34. ISBN 85-6330801-6. SISTEMA RENINA-ANGIOTENSINA; SISTEMA RENINA-ANGIOTENSINA. FUNCOES; INIBIDORES DO SISTEMA RENINA-ANGIOTENSINA; ANTAGONISTAS DOS RECEPTORES DE ANGIOTENSINA II |
| 8726/16820 | US=23-F / Câncer MacKeigan JP, Gaither LA. Role of RNA interference in understanding the molecular basis of cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 5-20. ISBN 978-90-481-3185-3. CANCER DE CABECA E PESCOCO; CANCER DE TIREOIDE; CANCER. TRATAMENTO; CANCER . DIAGNOSTICO; CANCER. TERAPIA |
| 8727/16820 | US=23-E / Câncer Gubbels JAA, Connor JP, Patankar MS. Role of MUC16 (CA125) in the pathogenesis of epithelial ovarian cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 71-84. ISBN 978-90-481-2917-1. MUC16; CA125 NA PATOGENESE DO CANCER EPITELIAL DE OVARIO; CANCER EPITELIAL DE OVARIO; CAMADAS DE DEFESA DO TUMOR DAS CELULAS |
| 8728/16820 | US=23-E / Câncer Takano M, Sasaki N, Sugiyama T. Clear cell carcinoma of the ovary: prognosis using cytoreductive surgery. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 85-91. ISBN 978-90-481-2917-1. |
| 8729/16820 | US=23-E / Câncer Dowdy SC, Cliby WA. Advanced ovarian cancer: prediction of surgical outcomes using computed tomograpy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 93-103. ISBN 978-90-481-2917-1. CANCER DE OVARIO AVANCADO; RESULTADOS CIRURGICOS; CITORREDUCAO |
| 8730/16820 | US=23-E / Câncer Merkle EM, Nelson RC, Lewin JS. Renal cell carcinoma: follow-up with magnetic resonance imaging after percutaneous radiofrequency ablation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 109-13. ISBN 978-90-481-2917-1. CARCINOMA DE CELULAS RENAIS; RESSONANCIA MAGNETICA APOS ABLACAO; RADIOFREQUENCIA PERCUTANEA; TUMOR RESIDUAL OU RECORRENTE |
| 8731/16820 | US=23-F / Câncer Yague E, Raguz S. Multidrug resistance. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 121-33. ISBN 978-90-481-3185-3. RESISTENCIA A MULTIPLAS DROGAS; QUIMIOTERAPIA TRADICIONAL; CANCER DE CELULAS-TRONCO. RESISTENCIA AS DROGAS |
| 8732/16820 | US=23-E / Câncer Quan JR WDY, Quan FM. Metastatic kidney cancer: treatment with infusional interleukin-2 plus famotidine. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 115-20. ISBN 978-90-481-2917-1. CANCER RENAL METASTATICO; TRATAMENTO COM INFUSAO DE INTERLEUCINA-2 |
| 8733/16820 | US=23-E / Câncer Klatte T, Böhm M. Renal cell carcinoma: preoperative treatment with cytokines followed by surgery. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 121-35. ISBN 978-90-481-2917-1. CARCINOMA DE CELULAS RENAIS; TRATAMENTO PRE-OPERATORIO COM CITOCINAS |
| 8734/16820 | US=23-E / Câncer Tomita Y, Maruyama R, Itoi T, Bilim V. Metastatic renal cell carcinoma: use of Bcl-2 and Fas to predict responses to immunotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 137-45. ISBN 978-90-481-2917-1. CARCINOMA; METASTATICO DE CELULAS RENAIS; BCL-2 E FAS; IMUNOTERAPIA |
| 8735/16820 | US=1-A / Farmacologia Mahley RW, Bersot TP. Terapia farmacológica para a hipercolesterolemia e a dislipidemia. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 837-68. ISBN 85-6330801-6. HIPERCOLESTEROLEMIA; DISLIPIDEMIA; METABOLISMO DAS LIPOPROTEINAS PLASMATICAS; HIPERLIPIDEMIA; ATEROSCLEROSE; NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP); DISLIPIDEMIA. TRATAMENTO FARMACOLOGICO; ESTATINA; SEQUESTRADORES DE ACIDOS BILIARES; NIACINA; DERIVADOS DO ACIDO FIBRICO; EZETIMIBA; PROTEINA DE TRANSFERENCIA DE ESTERES DE COLESTERIL |
| 8736/16820 | US=23-E / Câncer Ozluk Y. Wilms tumor: prognosis using microvessel density. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 147-55. ISBN 978-90-481-2917-1. TUMOR DE WILMS; DENSIDADE MICROVASCULAR. PROGNOSTICO; ANGIOGENESE |
| 8737/16820 | US=1-A / Farmacologia Hoogerwerf WA, Pasricha PJ. Farmacoterapia da acidez gástrica, úlceras pépticas e doença do refluxo gastroesofágico. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 869-81. ISBN 85-6330801-6. FISIOLOGIA DA SECRECAO GASTRICA; INIBIDORES DA BOMBA DE PROTONS; ANTAGONISTAS DOS RECEPTORES H2; SUCRALFATO; ANTIACIDOS; DISTURBIOS ACIDO-PEPTICOS; DOENCA POR REFLUXO GASTRESOFAGICO; DOENCA ULCEROSA PEPTICA |
| 8738/16820 | US=23-E / Câncer Burel-Vandenbos F, Cardot-Leccia N, Haudebourg J, Ambrosetti D, Michiels JF. Adenomatoid tumor of the adrenal gland: differential diagnosis using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 161-65. ISBN 978-90-481-2917-1. TUMOR ADENOMATOIDE DA GLANDULA SUPRA-RENAL; DIAGNOSTICO COM IMUNOISTOQUIMICA; IMUNOFENOTIPO |
| 8739/16820 | US=1-A / Farmacologia Pasricha PJ. Tratamento dos distúrbios da motilidade intestinal e do fluxo da água; antieméticos; fármacos usados nas doenças biliares e pancreáticas. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 883-906. ISBN 85-6330801-6. MOTILIDADE GASTRINTESTINAL; AGENTES PROCINETICOS; DOPAMINA; DOMPERIDONA; SEROTONINA; LAXANTES; CATARTICOS; PRISAO DE VENTRE; DIETA; AGENTES DIARREICOS; SINDROME DO COLON IRRITAVEL; ANTIESPASMODICOS; AGENTES ANTIEMETICOS; AGENTES ANTINAUSEANTES; DRONABINOL; ENZIMAS PANCREATICAS; ACIDOS BILIARES; AGENTES ANTIFLATULENTOS |
| 8740/16820 | US=23-E / Câncer Spiess PE, Tannir NM, Pisters LL. Testicular cancer: post-chemotherapy retroperitoneal lymph node dissection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 167-79. ISBN 978-90-481-2917-1. CANCER DE TESTICULO; POS-QUIMIOTERAPIA; RETROPERITONEAL DISSECCAO DE LINFONODOS |